BNC Wealth Management’s Idexx Laboratories IDXX Stock Holding History

BNC Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-63	Closed	-$25K	–	268
2020 Q3	$25K	Buy	+63	New	+$23.3K	0.02%	207

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

BNC Wealth Management's IDXX Position: Q4 2020 in Review

BNC Wealth Management sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 63 shares — an estimated $25K sold.

BNC Wealth Management first reported a position in IDXX in Q3 2020 and held it in 1 quarter. The position peaked at $25K in Q3 2020. 971 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

BNC Wealth Management reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
BNC Wealth Management sold 63 Idexx Laboratories shares in Q4 2020, an estimated $25K.
BNC Wealth Management first reported a position in Idexx Laboratories in Q3 2020 and held it in 1 quarter.
BNC Wealth Management's Idexx Laboratories position peaked at $25K in Q3 2020.
971 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.